NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 56 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | -54.5% | 46,539 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | 0.0% | 46,539 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | -35.3% | 46,539 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $17,000 | 0.0% | 46,539 | 0.0% | 0.00% | – |
| Q4 2017 | $17,000 | -10.5% | 46,539 | 0.0% | 0.00% | – |
| Q3 2017 | $19,000 | -20.8% | 46,539 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $24,000 | -11.1% | 46,539 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $27,000 | -10.0% | 46,539 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $30,000 | -30.2% | 46,539 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $43,000 | +72.0% | 46,539 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $25,000 | -43.2% | 46,539 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $44,000 | -29.0% | 46,539 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $62,000 | -26.2% | 46,539 | +27.0% | 0.00% | -33.3% |
| Q3 2015 | $84,000 | +394.1% | 36,639 | +255.1% | 0.00% | – |
| Q2 2015 | $17,000 | +6.2% | 10,317 | 0.0% | 0.00% | -100.0% |
| Q1 2015 | $16,000 | -15.8% | 10,317 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $19,000 | -44.1% | 10,317 | -55.0% | 0.00% | 0.0% |
| Q2 2014 | $34,000 | -19.0% | 22,904 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $42,000 | -37.3% | 22,904 | -29.1% | 0.00% | -33.3% |
| Q4 2013 | $67,000 | – | 32,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |